Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years... by Byung Wook Yoo, Hye Lim Jung, Yoon Seob Byeon, Dong Ki Han, Nak Yeong Jeong, Carlo Curina, Luca Moraschini, Sung Jin Kim, Chiranjiwi Bhusal, Michele Pellegrini, Yan Miao

Get full text